219 related articles for article (PubMed ID: 15953646)
1. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Crimean-Congo hemorrhagic fever.
Ergonul O
Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007.
Yilmaz GR; Buzgan T; Irmak H; Safran A; Uzun R; Cevik MA; Torunoglu MA
Int J Infect Dis; 2009 May; 13(3):380-6. PubMed ID: 18986819
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
14. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
16. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
[TBL] [Abstract][Full Text] [Related]
18. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.
Sharifi-Mood B; Metanat M; Ghorbani-Vaghei A; Fayyaz-Jahani F; Akrami E
Arch Iran Med; 2009 Mar; 12(2):151-3. PubMed ID: 19249885
[TBL] [Abstract][Full Text] [Related]
19. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
[TBL] [Abstract][Full Text] [Related]
20. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
